Literature DB >> 14557688

Multiple sclerosis in Northern Sardinia, Italy: a methodological approach for genetic epidemiological studies.

Maura Pugliatti1, Stefano Sotgiu, A Dessa Sadovnick, Irene M L Yee, M Alessandra Sotgiu, Charles M Poser, Giulio Rosati.   

Abstract

The etiopathogenesis of multiple sclerosis (MS) remains unclear. However, genetic factors are believed to be important in disease susceptibility. A methodological approach is presented for a population-based study aimed at investigating MS familial incidence and patterns of familial clustering in Northern Sardinia, Italy, with a reported MS prevalence of 150/100,000 population. Patients with MS since 1965 to the present and known to the MS Register for the province of Sassari will be asked to provide genealogical, comorbid and demographic information. Statistical analyses of the familial risk for MS will depend on the completeness of MS 'age at onset' data for affected individuals and age at the time family history is obtained (or age at death) for unaffected family members. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14557688     DOI: 10.1159/000072927

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  3 in total

1.  Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis.

Authors:  Fuencisla Matesanz; Blanca Rueda; Gisela Orozco; Oscar Fernandez; Laura Leyva; Antonio Alcina; Javier Martín
Journal:  J Neurol       Date:  2005-03-17       Impact factor: 4.849

2.  Linkage mapping of CVD risk traits in the isolated Norfolk Island population.

Authors:  C Bellis; H C Cox; T D Dyer; J C Charlesworth; K N Begley; S Quinlan; R A Lea; S C Heath; J Blangero; L R Griffiths
Journal:  Hum Genet       Date:  2008-10-31       Impact factor: 4.132

3.  Seasonal fluctuation of multiple sclerosis births in Sardinia.

Authors:  Stefano Sotgiu; M Pugliatti; Maria A Sotgiu; Maria L Fois; Giannina Arru; Alessandra Sanna; Giulio Rosati
Journal:  J Neurol       Date:  2005-07-20       Impact factor: 6.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.